_id
6915eb0cbc934aba376b1ca9
Ticker
QNCX
Name
Quince Therapeutics, Inc.
Exchange
NASDAQ
Address
611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.quincetx.com
Description
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Last Close
4.4
Volume
1144607
Current Price
4.22
Change
-4.090909090909104
Last Updated
2025-12-03T12:38:47.986Z
Image
data:image/webp;base64,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
Ipo Date
2019-05-09T00:00:00.000Z
Market Cap
188203440
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.75
Target Price
7.5
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
36000
Gross Profit
-36000
Operating Expenses
11328000
Operating Income
-11364000
Interest Expense
-
Pretax Income
-13488000
Net Income
-13442000
Eps
-0.24915029499435704
Dividends Per Share
-
Shares Outstanding
55681490
Income Tax Expense
-46000
EBITDA
-13452000
Operating Margin
-
Total Other Income Expense Net
-2124000
Cash
6452000
Short Term Investments
19836000
Receivables
-
Inventories
-
Total Current Assets
29202000
Property Plant Equipment
1097000
Total Assets
109899000
Payables
3403000
Short Term Debt
17634000
Long Term Debt
-
Total Liabilities
108840000
Equity
1059000
Depreciation
36000
Change In Working Capital
194000
Cash From Operations
-9928000
Capital Expenditures
74000
Cash From Investing
-1781000
Cash From Financing
1376000
Net Change In Cash
-10374000
PE
-
PB
214.99035469310672
ROE
-1269.3106704438148
ROA
-12.23123049345308
FCF
-10002000
Fcf Percent
-
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
36000
Quarters > 0 > income Statement > gross Profit
-36000
Quarters > 0 > income Statement > operating Expenses
11328000
Quarters > 0 > income Statement > operating Income
-11364000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-13488000
Quarters > 0 > income Statement > net Income
-13442000
Quarters > 0 > income Statement > eps
-0.24915029499435704
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
53951371
Quarters > 0 > income Statement > income Tax Expense
-46000
Quarters > 0 > income Statement > EBITDA
-13452000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-2124000
Quarters > 0 > balance Sheet > cash
6452000
Quarters > 0 > balance Sheet > short Term Investments
19836000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
29202000
Quarters > 0 > balance Sheet > property Plant Equipment
1097000
Quarters > 0 > balance Sheet > total Assets
109899000
Quarters > 0 > balance Sheet > payables
3403000
Quarters > 0 > balance Sheet > short Term Debt
17634000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
108840000
Quarters > 0 > balance Sheet > equity
1059000
Quarters > 0 > cash Flow > net Income
-13442000
Quarters > 0 > cash Flow > depreciation
36000
Quarters > 0 > cash Flow > change In Working Capital
194000
Quarters > 0 > cash Flow > cash From Operations
-9928000
Quarters > 0 > cash Flow > capital Expenditures
74000
Quarters > 0 > cash Flow > cash From Investing
-1781000
Quarters > 0 > cash Flow > cash From Financing
1376000
Quarters > 0 > cash Flow > net Change In Cash
-10374000
Quarters > 0 > ratios > PE
-0.24915029499435704
Quarters > 0 > ratios > PB
214.99035469310672
Quarters > 0 > ratios > ROE
-1269.3106704438148
Quarters > 0 > ratios > ROA
-12.23123049345308
Quarters > 0 > ratios > FCF
-10002000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
35000
Quarters > 1 > income Statement > gross Profit
-35000
Quarters > 1 > income Statement > operating Expenses
9860000
Quarters > 1 > income Statement > operating Income
-9895000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-15982000
Quarters > 1 > income Statement > net Income
-16049000
Quarters > 1 > income Statement > eps
-0.3437629662136631
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
46686239
Quarters > 1 > income Statement > income Tax Expense
67000
Quarters > 1 > income Statement > EBITDA
-15947000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-6087000
Quarters > 1 > balance Sheet > cash
16826000
Quarters > 1 > balance Sheet > short Term Investments
17882000
Quarters > 1 > balance Sheet > receivables
992000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
37345000
Quarters > 1 > balance Sheet > property Plant Equipment
1080000
Quarters > 1 > balance Sheet > total Assets
117210000
Quarters > 1 > balance Sheet > payables
1759000
Quarters > 1 > balance Sheet > short Term Debt
112000
Quarters > 1 > balance Sheet > long Term Debt
16989000
Quarters > 1 > balance Sheet > total Liabilities
105474000
Quarters > 1 > balance Sheet > equity
11736000
Quarters > 1 > cash Flow > net Income
-16049000
Quarters > 1 > cash Flow > depreciation
35000
Quarters > 1 > cash Flow > change In Working Capital
-1872000
Quarters > 1 > cash Flow > cash From Operations
-11415000
Quarters > 1 > cash Flow > capital Expenditures
126000
Quarters > 1 > cash Flow > cash From Investing
6039000
Quarters > 1 > cash Flow > cash From Financing
14412000
Quarters > 1 > cash Flow > net Change In Cash
9055000
Quarters > 1 > ratios > PE
-0.3437629662136631
Quarters > 1 > ratios > PB
16.78731497784594
Quarters > 1 > ratios > ROE
-136.75017041581458
Quarters > 1 > ratios > ROA
-13.69251770326764
Quarters > 1 > ratios > FCF
-11541000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
32000
Quarters > 2 > income Statement > gross Profit
-32000
Quarters > 2 > income Statement > operating Expenses
14858000
Quarters > 2 > income Statement > operating Income
-14858000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-14983000
Quarters > 2 > income Statement > net Income
-15030000
Quarters > 2 > income Statement > eps
-0.34204812637620036
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
43941185
Quarters > 2 > income Statement > income Tax Expense
47000
Quarters > 2 > income Statement > EBITDA
-12902000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-125000
Quarters > 2 > balance Sheet > cash
7771000
Quarters > 2 > balance Sheet > short Term Investments
23828000
Quarters > 2 > balance Sheet > receivables
916000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
33829000
Quarters > 2 > balance Sheet > property Plant Equipment
941000
Quarters > 2 > balance Sheet > total Assets
107089000
Quarters > 2 > balance Sheet > payables
3008000
Quarters > 2 > balance Sheet > short Term Debt
102000
Quarters > 2 > balance Sheet > long Term Debt
15266000
Quarters > 2 > balance Sheet > total Liabilities
88508000
Quarters > 2 > balance Sheet > equity
18581000
Quarters > 2 > cash Flow > net Income
-15030000
Quarters > 2 > cash Flow > depreciation
32000
Quarters > 2 > cash Flow > change In Working Capital
2051000
Quarters > 2 > cash Flow > cash From Operations
-9601000
Quarters > 2 > cash Flow > capital Expenditures
148000
Quarters > 2 > cash Flow > cash From Investing
10898000
Quarters > 2 > cash Flow > cash From Financing
87000
Quarters > 2 > cash Flow > net Change In Cash
1559000
Quarters > 2 > ratios > PE
-0.34204812637620036
Quarters > 2 > ratios > PB
9.979645912491254
Quarters > 2 > ratios > ROE
-80.88908024325924
Quarters > 2 > ratios > ROA
-14.035054954290358
Quarters > 2 > ratios > FCF
-9749000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
168000
Quarters > 3 > income Statement > cost Of Revenue
16000
Quarters > 3 > income Statement > gross Profit
-16000
Quarters > 3 > income Statement > operating Expenses
10093000
Quarters > 3 > income Statement > operating Income
-10109000
Quarters > 3 > income Statement > interest Expense
2929000
Quarters > 3 > income Statement > pretax Income
-12451000
Quarters > 3 > income Statement > net Income
-12458000
Quarters > 3 > income Statement > eps
-0.2879645540551745
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
43262269
Quarters > 3 > income Statement > income Tax Expense
7000
Quarters > 3 > income Statement > EBITDA
-12435000
Quarters > 3 > income Statement > operating Margin
-6017.2619047619055
Quarters > 3 > income Statement > total Other Income Expense Net
-2342000
Quarters > 3 > balance Sheet > cash
6212000
Quarters > 3 > balance Sheet > short Term Investments
34572000
Quarters > 3 > balance Sheet > receivables
882000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
44036000
Quarters > 3 > balance Sheet > property Plant Equipment
813000
Quarters > 3 > balance Sheet > total Assets
114478000
Quarters > 3 > balance Sheet > payables
2903000
Quarters > 3 > balance Sheet > short Term Debt
96000
Quarters > 3 > balance Sheet > long Term Debt
14321000
Quarters > 3 > balance Sheet > total Liabilities
84332000
Quarters > 3 > balance Sheet > equity
30146000
Quarters > 3 > cash Flow > net Income
-12458000
Quarters > 3 > cash Flow > depreciation
16000
Quarters > 3 > cash Flow > change In Working Capital
1895000
Quarters > 3 > cash Flow > cash From Operations
-7552000
Quarters > 3 > cash Flow > capital Expenditures
133000
Quarters > 3 > cash Flow > cash From Investing
10867000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
3537000
Quarters > 3 > ratios > PE
-0.2879645540551745
Quarters > 3 > ratios > PB
6.056086219730644
Quarters > 3 > ratios > ROE
-41.32554899489153
Quarters > 3 > ratios > ROA
-10.882440294204999
Quarters > 3 > ratios > FCF
-7685000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-45.74404761904762
Quarters > 3 > health Score
13
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
186000
Annuals > 0 > income Statement > gross Profit
-186000
Annuals > 0 > income Statement > operating Expenses
57285000
Annuals > 0 > income Statement > operating Income
-57285000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-56741000
Annuals > 0 > income Statement > net Income
-56828000
Annuals > 0 > income Statement > eps
-1.3135695679761965
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
43262269
Annuals > 0 > income Statement > income Tax Expense
87000
Annuals > 0 > income Statement > EBITDA
-35984000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
544000
Annuals > 0 > balance Sheet > cash
6212000
Annuals > 0 > balance Sheet > short Term Investments
34572000
Annuals > 0 > balance Sheet > receivables
882000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
44036000
Annuals > 0 > balance Sheet > property Plant Equipment
813000
Annuals > 0 > balance Sheet > total Assets
114478000
Annuals > 0 > balance Sheet > payables
2903000
Annuals > 0 > balance Sheet > short Term Debt
96000
Annuals > 0 > balance Sheet > long Term Debt
14321000
Annuals > 0 > balance Sheet > total Liabilities
84332000
Annuals > 0 > balance Sheet > equity
30146000
Annuals > 0 > cash Flow > net Income
-56828000
Annuals > 0 > cash Flow > depreciation
186000
Annuals > 0 > cash Flow > change In Working Capital
-484000
Annuals > 0 > cash Flow > cash From Operations
-31904000
Annuals > 0 > cash Flow > capital Expenditures
257000
Annuals > 0 > cash Flow > cash From Investing
21908000
Annuals > 0 > cash Flow > cash From Financing
-4775000
Annuals > 0 > cash Flow > net Change In Cash
-14540000
Annuals > 0 > ratios > PE
-1.3135695679761965
Annuals > 0 > ratios > PB
4.850609341869568
Annuals > 0 > ratios > ROE
-188.50925495919856
Annuals > 0 > ratios > ROA
-49.64097905274376
Annuals > 0 > ratios > FCF
-32161000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
15
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
322000
Annuals > 1 > income Statement > gross Profit
-322000
Annuals > 1 > income Statement > operating Expenses
34620000
Annuals > 1 > income Statement > operating Income
-34620000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-31582000
Annuals > 1 > income Statement > net Income
-31385000
Annuals > 1 > income Statement > eps
-0.8428411100968014
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
37237149
Annuals > 1 > income Statement > income Tax Expense
-197000
Annuals > 1 > income Statement > EBITDA
-26820000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
3038000
Annuals > 1 > balance Sheet > cash
20752000
Annuals > 1 > balance Sheet > short Term Investments
54307000
Annuals > 1 > balance Sheet > receivables
993000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
77440000
Annuals > 1 > balance Sheet > property Plant Equipment
619000
Annuals > 1 > balance Sheet > total Assets
180204000
Annuals > 1 > balance Sheet > payables
2033000
Annuals > 1 > balance Sheet > short Term Debt
64000
Annuals > 1 > balance Sheet > long Term Debt
13429000
Annuals > 1 > balance Sheet > total Liabilities
95120000
Annuals > 1 > balance Sheet > equity
85084000
Annuals > 1 > cash Flow > net Income
-31385000
Annuals > 1 > cash Flow > depreciation
322000
Annuals > 1 > cash Flow > change In Working Capital
1977000
Annuals > 1 > cash Flow > cash From Operations
-18292000
Annuals > 1 > cash Flow > capital Expenditures
160000
Annuals > 1 > cash Flow > cash From Investing
-5758000
Annuals > 1 > cash Flow > cash From Financing
143000
Annuals > 1 > cash Flow > net Change In Cash
-23827000
Annuals > 1 > ratios > PE
-0.8428411100968014
Annuals > 1 > ratios > PB
1.479262418551079
Annuals > 1 > ratios > ROE
-36.88707630106718
Annuals > 1 > ratios > ROA
-17.416372555548158
Annuals > 1 > ratios > FCF
-18452000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
175000
Annuals > 2 > income Statement > gross Profit
-175000
Annuals > 2 > income Statement > operating Expenses
52015000
Annuals > 2 > income Statement > operating Income
-52015000
Annuals > 2 > income Statement > interest Expense
568000
Annuals > 2 > income Statement > pretax Income
-51944000
Annuals > 2 > income Statement > net Income
-51660000
Annuals > 2 > income Statement > eps
-1.5422491635179079
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
33496533
Annuals > 2 > income Statement > income Tax Expense
-284000
Annuals > 2 > income Statement > EBITDA
-50986000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
71000
Annuals > 2 > balance Sheet > cash
44579000
Annuals > 2 > balance Sheet > short Term Investments
45602000
Annuals > 2 > balance Sheet > receivables
1003000
Annuals > 2 > balance Sheet > inventories
2288000
Annuals > 2 > balance Sheet > total Current Assets
93748000
Annuals > 2 > balance Sheet > property Plant Equipment
684000
Annuals > 2 > balance Sheet > total Assets
103910000
Annuals > 2 > balance Sheet > payables
570000
Annuals > 2 > balance Sheet > short Term Debt
453000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3317000
Annuals > 2 > balance Sheet > equity
100593000
Annuals > 2 > cash Flow > net Income
-51660000
Annuals > 2 > cash Flow > depreciation
204000
Annuals > 2 > cash Flow > change In Working Capital
-9829000
Annuals > 2 > cash Flow > cash From Operations
-44038000
Annuals > 2 > cash Flow > capital Expenditures
133000
Annuals > 2 > cash Flow > cash From Investing
18002000
Annuals > 2 > cash Flow > cash From Financing
707000
Annuals > 2 > cash Flow > net Change In Cash
-25145000
Annuals > 2 > ratios > PE
-1.5422491635179079
Annuals > 2 > ratios > PB
1.1255085497002775
Annuals > 2 > ratios > ROE
-51.35546210968954
Annuals > 2 > ratios > ROA
-49.71610047156193
Annuals > 2 > ratios > FCF
-44171000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
344000
Annuals > 3 > income Statement > gross Profit
-344000
Annuals > 3 > income Statement > operating Expenses
90318000
Annuals > 3 > income Statement > operating Income
-90318000
Annuals > 3 > income Statement > interest Expense
373000
Annuals > 3 > income Statement > pretax Income
-89945000
Annuals > 3 > income Statement > net Income
-89945000
Annuals > 3 > income Statement > eps
-3.026565332725676
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
29718506
Annuals > 3 > income Statement > income Tax Expense
-620000
Annuals > 3 > income Statement > EBITDA
-89974000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
373000
Annuals > 3 > balance Sheet > cash
69724000
Annuals > 3 > balance Sheet > short Term Investments
37078000
Annuals > 3 > balance Sheet > receivables
1128000
Annuals > 3 > balance Sheet > inventories
2248000
Annuals > 3 > balance Sheet > total Current Assets
111673000
Annuals > 3 > balance Sheet > property Plant Equipment
1428000
Annuals > 3 > balance Sheet > total Assets
133228000
Annuals > 3 > balance Sheet > payables
4911000
Annuals > 3 > balance Sheet > short Term Debt
741000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
14642000
Annuals > 3 > balance Sheet > equity
118586000
Annuals > 3 > cash Flow > net Income
-89945000
Annuals > 3 > cash Flow > depreciation
344000
Annuals > 3 > cash Flow > change In Working Capital
-4261000
Annuals > 3 > cash Flow > cash From Operations
-62932000
Annuals > 3 > cash Flow > capital Expenditures
180000
Annuals > 3 > cash Flow > cash From Investing
58952000
Annuals > 3 > cash Flow > cash From Financing
6808000
Annuals > 3 > cash Flow > net Change In Cash
2883000
Annuals > 3 > ratios > PE
-3.026565332725676
Annuals > 3 > ratios > PB
0.8470523525542645
Annuals > 3 > ratios > ROE
-75.84790784746934
Annuals > 3 > ratios > ROA
-67.51208454679197
Annuals > 3 > ratios > FCF
-63112000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.24915029499435704
Valuation > metrics > PB
214.99035469310672
Valuation > final Score
20
Valuation > verdict
7066.3% Overvalued
Profitability > metrics > ROE
-1269.3106704438148
Profitability > metrics > ROA
-46.03109376070132
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
102.77620396600567
Risk > metrics > Interest Coverage
-315.6666666666667
Risk > final Score
-1257
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.388125683319865
Liquidity > metrics > Quick Ratio
1.388125683319865
Liquidity > final Score
85
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1125
Prev Risks > 1
-23
Prev Risks > 2
4
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:04:34.595Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.25
Earnings History > 0 > eps Estimate
-0.2167
Earnings History > 0 > eps Difference
-0.0333
Earnings History > 0 > surprise Percent
-15.3669
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.34
Earnings History > 1 > eps Estimate
-0.26
Earnings History > 1 > eps Difference
-0.08
Earnings History > 1 > surprise Percent
-30.7692
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.34
Earnings History > 2 > eps Estimate
-0.23
Earnings History > 2 > eps Difference
-0.11
Earnings History > 2 > surprise Percent
-47.8261
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2839
Earnings History > 3 > eps Estimate
-0.1
Earnings History > 3 > eps Difference
-0.1839
Earnings History > 3 > surprise Percent
-183.9
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1272
Earnings History > 4 > eps Estimate
-0.1
Earnings History > 4 > eps Difference
-0.0272
Earnings History > 4 > surprise Percent
-27.2
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.6434
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-01
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2171
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-14
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.22
Earnings History > 7 > eps Estimate
-0.28
Earnings History > 7 > eps Difference
0.06
Earnings History > 7 > surprise Percent
21.4286
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.1483
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.136
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.136
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.3418
Earnings History > 10 > eps Estimate
-0.3092
Earnings History > 10 > eps Difference
-0.0326
Earnings History > 10 > surprise Percent
-10.5433
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-15
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.15
Earnings History > 11 > eps Estimate
-0.2876
Earnings History > 11 > eps Difference
0.1376
Earnings History > 11 > surprise Percent
47.8442
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.22
Earnings History > 12 > eps Estimate
-0.28
Earnings History > 12 > eps Difference
0.06
Earnings History > 12 > surprise Percent
21.4286
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.51
Earnings History > 13 > eps Estimate
-0.48
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-6.25
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.72
Earnings History > 14 > eps Estimate
-0.55
Earnings History > 14 > eps Difference
-0.17
Earnings History > 14 > surprise Percent
-30.9091
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-01
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.78
Earnings History > 15 > eps Estimate
-0.65
Earnings History > 15 > eps Difference
-0.13
Earnings History > 15 > surprise Percent
-20
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-10-29
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.73
Earnings History > 16 > eps Estimate
-0.74
Earnings History > 16 > eps Difference
0.01
Earnings History > 16 > surprise Percent
1.3514
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-06
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.74
Earnings History > 17 > eps Estimate
-0.76
Earnings History > 17 > eps Difference
0.02
Earnings History > 17 > surprise Percent
2.6316
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.78
Earnings History > 18 > eps Estimate
-0.72
Earnings History > 18 > eps Difference
-0.06
Earnings History > 18 > surprise Percent
-8.3333
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-01
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.69
Earnings History > 19 > eps Estimate
-0.73
Earnings History > 19 > eps Difference
0.04
Earnings History > 19 > surprise Percent
5.4795
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.73
Earnings History > 20 > eps Estimate
-0.62
Earnings History > 20 > eps Difference
-0.11
Earnings History > 20 > surprise Percent
-17.7419
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-14
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.6
Earnings History > 21 > eps Estimate
-0.62
Earnings History > 21 > eps Difference
0.02
Earnings History > 21 > surprise Percent
3.2258
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-12
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.61
Earnings History > 22 > eps Estimate
-0.44
Earnings History > 22 > eps Difference
-0.17
Earnings History > 22 > surprise Percent
-38.6364
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-16
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.35
Earnings History > 23 > eps Estimate
-0.4
Earnings History > 23 > eps Difference
0.05
Earnings History > 23 > surprise Percent
12.5
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.37
Earnings History > 24 > eps Estimate
-0.37
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
0
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-09
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.57
Earnings History > 25 > eps Estimate
-0.37
Earnings History > 25 > eps Difference
-0.2
Earnings History > 25 > surprise Percent
-54.0541
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-12
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.61
Earnings History > 26 > eps Estimate
-0.23
Earnings History > 26 > eps Difference
-1.38
Earnings History > 26 > surprise Percent
-600
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACitizens reiterates Market Outperform rating on Quince Therapeutics stock By Investing.com Investing.com Nigeria
Read more →Quince Therapeutics (QNCX) publishes eDSP lung, IBD data before Phase 3 results in 2026 Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7.5
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 18.12% of the total shares of Quince Therapeutics, Inc.
1.
Nantahala Capital Management, LLC(4.707%)
since
2025/06/30
2.
Vanguard Group Inc(2.707%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(1.759%)
since
2025/07/31
4.
IEQ CAPITAL, LLC(0.8178%)
since
2025/06/30
5.
Geode Capital Management, LLC(0.7391%)
since
2025/06/30
6.
Renaissance Technologies Corp(0.7071%)
since
2025/06/30
7.
Vanguard Institutional Extnd Mkt Idx Tr(0.7054%)
since
2025/07/31
8.
Rockefeller Capital Management L.P.(0.6313%)
since
2025/06/30
9.
BlackRock Inc(0.625%)
since
2025/06/30
10.
HighTower Advisors, LLC(0.5743%)
since
2025/06/30
11.
Fidelity Extended Market Index(0.3644%)
since
2025/07/31
12.
Alphabet Inc(0.3521%)
since
2025/06/30
13.
Shay Capital LLC(0.2793%)
since
2025/06/30
14.
ADAR1 Capital Management LLC(0.2661%)
since
2025/06/30
15.
Bridgeway Capital Management, LLC(0.2394%)
since
2025/06/30
16.
State Street Corp(0.2325%)
since
2025/06/30
17.
Mariner Wealth Advisors LLC(0.228%)
since
2025/06/30
18.
Union Square Park Capital Management, LLC(0.225%)
since
2025/06/30
19.
Millennium Management LLC(0.2061%)
since
2025/06/30
20.
Citadel Advisors Llc(0.1748%)
since
2025/06/30
21.
Scharf Investments(0.1695%)
since
2025/06/30
22.
iShares Micro-Cap ETF(0.1497%)
since
2025/08/31
23.
Northern Trust Corp(0.1443%)
since
2025/06/30
24.
Bridgeway Ultra-Small Company Market(0.1358%)
since
2025/06/30
25.
Fidelity Total Market Index(0.1159%)
since
2025/07/31
26.
Intellectus Partners, LLC(0.0993%)
since
2025/06/30
27.
Fidelity Series Total Market Index(0.0944%)
since
2025/07/31
28.
Northern Trust Extended Eq Market Idx(0.0786%)
since
2025/06/30
29.
NT Ext Equity Mkt Idx Fd - L(0.0786%)
since
2025/06/30
30.
Spartan Extended Market Index Pool F(0.0769%)
since
2025/07/31
31.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.0651%)
since
2025/07/31
32.
Bridgeway Ultra-Small Company(0.0624%)
since
2025/06/30
33.
NT Ext Equity Mkt Idx Fd - NL(0.062%)
since
2025/06/30
34.
Extended Equity Market Fund K(0.0559%)
since
2025/06/30
35.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0482%)
since
2025/06/30
36.
Fidelity Nasdaq Composite Index(0.0472%)
since
2025/07/31
37.
Spartan Total Market Index Pool G(0.0434%)
since
2025/07/31
38.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0222%)
since
2025/06/30
39.
Blackrock US Eq Mkt Fund CF(0.0155%)
since
2025/07/31
40.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0151%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.25
EPS Estimate
-0.2167
EPS Difference
-0.0333
Surprise Percent
-15.3669%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.